Fluocinolone Acetonide Solution Topical Solution USP
Failed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D.
Yes — there is an active recall. 1 ongoing FDA recall mention Fluocinolone (36 total). Check the affected lots below.
Most common reason: Wrong potency / content (21 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Fluocinolone. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Failed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D.
Failed Excipient Specifications: OOS for assay of Isopropyl Alcohol
Presence of Foreign Substance: Potential for broken glass within the glass pipette of the dropper.
Lack of Processing Controls (lack of assurance of conformity to specifications).
Lack of Processing Controls (lack of assurance of conformity to specifications).
Lack of Processing Control
Failed Impurities/Degradation Specifications: Expansion of October 2018 recall due to elevated out of specification results for total impurities that have been chemically identified as oxidative degradation products of the fluocinolone active pharmaceutical ingredient.
Failed Impurities/Degradation Specifications:Out of specification result noticed for total impurities observed during stability analysis
Failed Impurities and Degradation Specifications and Subpotent Drug: out-of-specification (OOS) test results for below assay and above specification for degradants.
Subpotent Drug
Subpotent Drug
Subpotent Drug
Chemical Contamination
Lack of Assurance of Sterility: There are also CGMP Deviations.
Lack of Assurance of Sterility: There are also CGMP Deviations.
Lack of Assurance of Sterility: There are also CGMP Deviations.
Lack of Assurance of Sterility: There are also CGMP Deviations.
Lack of Assurance of Sterility: There are also CGMP Deviations.
Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.
Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.
Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.
Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.
Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.
Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.
Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.